CAXTON CORP Diversified Active

Location: Princeton, NJ

CIK: 0001388551 · Show all filings

Period: Q3 2018 (← Previous) (Next →)

Filing Date: Nov 14, 2018

Total Value: $108M (100.0% shares, 0.0% debt)

Holdings (29)

— STRONGBRIDGE BIOPHARMA PLC 28.2%
Value $30.53M Shares 6,294,789 Share Price $4.85 Est. Cost/Share $2.84 Unrealized @ Report Date —
— MEI PHARMA INC 14.7%
Value $15.86M Shares 3,678,600 Share Price $4.31 Est. Cost/Share $3.94 Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 13.8%
Value $14.91M Shares 51,279 Share Price $290.72 Est. Cost/Share — Unrealized @ Report Date —
— GARRISON CAP INC 8.5%
Value $9.212M Shares 1,112,517 Share Price $8.28 Est. Cost/Share $8.42 Unrealized @ Report Date —
— MOLECULAR TEMPLATES INC 8.0%
Value $8.62M Shares 1,599,241 Share Price $5.39 Est. Cost/Share $6.43 Unrealized @ Report Date —
— CM FIN INC 7.1%
Value $7.698M Shares 895,173 Share Price $8.60 Est. Cost/Share $8.35 Unrealized @ Report Date —
— SCYNEXIS INC 4.8%
Value $5.19M Shares 4,325,000 Share Price $1.20 Est. Cost/Share $1.30 Unrealized @ Report Date —
— ALPS ETF TR 4.1%
Value $4.469M Shares 418,416 Share Price $10.68 Est. Cost/Share $10.10 Unrealized @ Report Date —
BRK/B BERKSHIRE HATHAWAY INC DEL 1.8%
Value $1.994M Shares 9,312 Share Price $214.13 * Est. Cost/Share $135.71 Unrealized @ Report Date +51.2%
JBGS JBG SMITH PPTYS 1.4%
Value $1.516M Shares 41,170 Share Price $36.82 Est. Cost/Share $34.27 Unrealized @ Report Date —
PCG PG&E CORP 1.0%
Value $1.035M Shares 22,500 Share Price $46.00 * Est. Cost/Share $41.94 Unrealized @ Report Date +5.0%
UHAL AMERCO 0.9%
Value $963K Shares 2,700 Share Price $356.67 * Est. Cost/Share $35.55 Unrealized @ Report Date +3.8%
— TAPIMMUNE INC 0.7%
Value $738K Shares 81,540 Share Price $9.05 Est. Cost/Share $9.42 Unrealized @ Report Date —
KURA KURA ONCOLOGY INC 0.6%
Value $607K Shares 34,708 Share Price $17.49 * Est. Cost/Share $18.11 Unrealized @ Report Date +5.8%
ACRS ACLARIS THERAPEUTICS INC 0.5%
Value $577K Shares 39,755 Share Price $14.51 * Est. Cost/Share $20.72 Unrealized @ Report Date -17.3%
— ARQULE INC 0.5%
Value $511K Shares 90,254 Share Price $5.66 Est. Cost/Share $5.65 Unrealized @ Report Date —
— KALA PHARMACEUTICALS INC 0.5%
Value $506K Shares 51,259 Share Price $9.87 Est. Cost/Share $9.87 Unrealized @ Report Date —
— CTI BIOPHARMA CORP 0.4%
Value $427K Shares 197,459 Share Price $2.16 Est. Cost/Share $2.16 Unrealized @ Report Date —
— INTEC PHARMA LTD JERUSALEM 0.3%
Value $364K Shares 64,396 Share Price $5.65 Est. Cost/Share $8.94 Unrealized @ Report Date —
— ALCENTRA CAP CORP 0.3%
Value $345K Shares 57,677 Share Price $5.98 Est. Cost/Share $8.20 Unrealized @ Report Date —
— EIGER BIOPHARMACEUTICALS INC 0.3%
Value $306K Shares 25,494 Share Price $12.00 Est. Cost/Share $12.00 Unrealized @ Report Date —
CPRX CATALYST PHARMACEUTICALS INC 0.3%
Value $276K Shares 72,967 Share Price $3.78 * Est. Cost/Share $3.21 Unrealized @ Report Date -2.5%
— SPRING BK PHARMACEUTICALS IN 0.2%
Value $253K Shares 20,986 Share Price $12.06 Est. Cost/Share $12.06 Unrealized @ Report Date —
— FAR PT ACQUISITION CORP 0.2%
Value $237K Shares 23,030 Share Price $10.29 Est. Cost/Share $10.18 Unrealized @ Report Date —
— DICERNA PHARMACEUTICALS INC 0.2%
Value $225K Shares 14,724 Share Price $15.28 Est. Cost/Share $15.28 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 0.2%
Value $222K Shares 111,217 Share Price $2.00 Est. Cost/Share $2.05 Unrealized @ Report Date —
— MARINUS PHARMACEUTICALS INC 0.2%
Value $202K Shares 20,180 Share Price $10.01 Est. Cost/Share $7.04 Unrealized @ Report Date —
CACC CREDIT ACCEP CORP MICH 0.2%
Value $201K Shares 459 Share Price $437.91 * Est. Cost/Share $419.51 Unrealized @ Report Date 0.0%
— SIERRA ONCOLOGY INC 0.2%
Value $190K Shares 111,898 Share Price $1.70 Est. Cost/Share $1.81 Unrealized @ Report Date —